Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients
Shih-Ya Ma, MD1,
Lai-Chu See, PhD2,
Chyong-Huey Lai, MD3,
Hung-Hsueh Chou, MD3,
Chien-Sheng Tsai, MD4,
Koon-Kwan Ng, MD5,
Swei Hsueh, MD6,
Wuu-Jyh Lin, PhD7,
Jenn-Tzong Chen, MSc7 and
Tzu-Chen Yen, MD, PhD1
1 Department of Nuclear Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
2 Biostatistics Consulting Center, Department of Public Health, Chang Gung University, Taoyuan, Taiwan
3 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
4 Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
5 Department of Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
6 Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
7 Institute of Nuclear Energy Research, Taoyuan, Taiwan

View larger version (56K):
[in a new window]
|
FIGURE 1. A 52-y-old woman with cervical cancer stage IVb. (A) 18F-FDG PET scan reveals focal area of slightly increased 18F-FDG-6-phosphate accumulation in right lower PALN (arrow; SUV = 2.49; score 2) in 40-min PET scan. (B) In 3-h scan, lesion is more clearly evident (arrow; SUV = 3.37, RI = 35.34%; score 3).
|
|

View larger version (63K):
[in a new window]
|
FIGURE 2. A 74-y-old woman had previously treated cervical cancer with unexplained elevated SCC-Ag tumor marker. (A) 18F-FDG PET scan shows increased 18F-FDG-6-phosphate accumulation in left lower PALNs in 40-min scan (arrow; SUV = 6.96; score 4). (B) In 3-h scan, previous lesion is not well demonstrated (arrow).
|
|
Copyright © 2003 by the Society of Nuclear Medicine.